Literature DB >> 2202476

Treatment of residual disease in acute leukemia patients with recombinant interleukin 2 (IL2): clinical and biological findings.

R Foa1, G Meloni, S Tosti, A Novarino, S Fenu, A Guarini, S Cardona, A Gillio Tos, F Gavosto, F Mandelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2202476

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  1 in total

1.  Continuous intravenous infusion of high-dose recombinant interleukin-2 for acute myeloid leukaemia--a phase II study.

Authors:  S H Lim; A C Newland; S Kelsey; A Bell; E Offerman; C Rist; D Gozzard; D Bareford; M P Smith; A H Goldstone
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.